Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Accurate and noninvasive detection of isocitrate dehydrogenase (IDH, including IDH1 and IDH2) status is clinically meaningful for molecular stratification of glioma, but remains challenging.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To establish a model for classifying IDH status in gliomas based on multiparametric MRI.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective, radiomics.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>In all, 105 consecutive cases of grade II–IV glioma with 50 IDH1 or IDH2 mutant (IDHm) and 55 IDH wildtype (IDHw) were separated into a training cohort (<i>n =</i> 73) and a test cohort (<i>n =</i> 32). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>Contrast‐enhanced T<sub>1</sub>‐weighted (CE‐T<sub>1</sub>W), T<sub>2</sub>‐weighted (T<sub>2</sub>W), and arterial spin labeling (ASL) images were acquired at 3.0T. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Two doctors manually labeled the volume of interest (VOI) on CE‐T<sub>1</sub>W, then T<sub>2</sub>W and ASL were coregistered to CE‐T<sub>1</sub>W. A total of 851 radiomics features were extracted on each VOI of three sequences. From the training cohort, all radiomics features with age and gender were processed by the Mann–Whitney <i>U</i>‐test, Pearson test, and least absolute shrinkage and selection operator to obtain optimal feature groups to train support vector machine models. The accuracy and area under curve (AUC) of all models for classifying the IDH status were calculated on the test cohort. Two subtasks were performed to verify the efficiency of texture features and the Pearson test in IDH status classification, respectively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>The permutation test with Bonferroni correction; chi‐square test.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The accuracy and AUC of the classifier, which combines the features of all three sequences, achieved 0.823 and 0.770 (<i>P</i> < 0.05), respectively. The best model established by texture features only had an AUC of 0.819 and an accuracy of 0.761. The best model established without the Pearson test got an AUC of 0.747 and an accuracy of 0.719. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>IDH genotypes of glioma can be identified by radiomics features from multiparameter MRI. The Pearson test improved the performance of the IDH classification models.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>4</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>1</p></section>

Insight into deep learning for glioma IDH medical image analysis: A systematic review

Deep Learning Can Differentiate IDH-Mutant from IDH-Wild GBM

Diagnostic Performance of Deep Learning for Predicting Gliomas' IDH and 1p/19q Status in MRI: A Systematic Review and Meta-Analysis

Predicting IDH mutation status as well as Ki-67 and p53 expression in high-grade gliomas using amide proton transfer-weighted and arterial spin labeling MRI

Path-39. Ai-Based Identification Of Glioma Idh Mutational Status From H&E-Stained Whole Slide Images

Automated Machine-Learning Framework Integrating Histopathological and Radiological Information for Predicting IDH1 Mutation Status in Glioma

Predictive Role of the Apparent Diffusion Coefficient and MRI Morphologic Features on IDH Status in Patients With Diffuse Glioma: A Retrospective Cross-Sectional Study

Bios-06. Machine Learning Model Independently Identifies Clinical Features Associated With Wild-Type Glioblastoma Versus Mutant Grade 4 Astrocytoma

Deep Neural Network Analysis of Pathology Images With Integrated Molecular Data for Enhanced Glioma Classification and Grading

Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach.

Prediction of overall survival and molecular markers in gliomas via analysis of digital pathology images using deep learning

Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting

The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.

Predicting IDH Mutation Status in Low-Grade Gliomas Based on Optimal Radiomic Features Combined with Multi-Sequence Magnetic Resonance Imaging

IDH1 Mutation Detection by Droplet Digital PCR in Glioma.

Predicting Isocitrate Dehydrogenase ( IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features

Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma

Deep-learning and conventional radiomics to predict IDH genotyping status based on magnetic resonance imaging data in adult diffuse glioma

Noninvasive Idh1 Mutation Estimation Based on A Quantitative Radiomics Approach for Grade Ii Glioma

GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning

Comparison of MRI Sequences to Predict IDH Mutation Status in Gliomas Using Radiomics-Based Machine Learning